trial
as of 2026-07-01Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder
NCTId NCT00179062
at a glance
— · Completed
Enrollment 300 (actual)
Sponsored by Vanderbilt University Medical Center
Primary completion 2007-06
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
300 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2000-02
Primary completion
2007-06
Eligibility
ALL · 18 Years · 60 Years
Interventions & indications
Sponsors
Vanderbilt University Medical CenterLead Sponsor
Investigators
1
Herbert Y Meltzer, M.D.Principal Investigator
Sites
1 total
Nashville, United States
Facts & assertions
4 sourced
Enrollment
300
Phase
NA
Primary Completion Date
2007-06
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
indication
investigator
person